Zinc Sulphate vs. Zinc Amino Acid Chelate
ZAZO
Effect of Zinc Sulphate and Zinc Amino Acid Chelate in Prevention Acute Diarrhea and Acute Respiratory Infection, Medellín 2012
1 other identifier
interventional
360
1 country
1
Brief Summary
Acute respiratory infection and acute diarrhea are among the most prevalent diseases of childhood increase the burden of morbidity and mortality in children under 5 years. Among the possible strategies for its prevention is important to count on good nutritional status for use in developing a good immune response to infections. Zinc deficiency has been shown to favor the development of infections and has been considered a real public health problem. Within the zinc compounds used are zinc amino acid chelate and zinc sulphate, the first that has shown evidence of being better absorbed and tolerated. We propose a study showing the effectiveness of zinc amino acid chelate and zinc sulphate in the prevention of acute diarrheal disease and acute respiratory infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2012
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2012
CompletedFirst Submitted
Initial submission to the registry
February 13, 2013
CompletedFirst Posted
Study publicly available on registry
February 15, 2013
CompletedFebruary 15, 2013
February 1, 2013
4 months
February 13, 2013
February 13, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Incidence acute diarrheal disease and acute respiratory infection
Preschool children will drink fortified milk with zinc amino acid chelate, zinc sulfate or milk without fortification. Fortnightly monitoring will be investigating the presence of infection (acute diarrheal disease and respiratory infections). Supervision and monitoring will be carried out for four months.
Up to 16 weeks
Secondary Outcomes (1)
Adverse reaction
Fortnightly. During 4 months of intervention
Study Arms (3)
Zinc sulphate
ACTIVE COMPARATORPreschool children healthy enrolled in FAN Foundation of Medellin, which will be supplied with zinc sulphate
Zinc Amino Acid Chelate
EXPERIMENTALPreschool children healthy enrolled in FAN Foundation of Medellin , which will be supplied with zinc amino acid chelate
Milk without fortification
PLACEBO COMPARATORMilk without zinc
Interventions
Zinc sulfate as dietary supplementation
Zinc amino acid chelate as dietary supplementation
Milk without fortification
Eligibility Criteria
You may qualify if:
- Children who
- Belong to institute FAN in Medellín
- Attend full time to institute FAN (eight hours)
- Have 2 to 5 years
You may not qualify if:
- Children who
- Children at the began of the study are with acute diarrheal disease and acute respiratory infection.
- Recurrent pneumonia, cystic fibrosis, gastrointestinal malformations, persistent diarrhea of any cause, inflammatory bowel disease.
- Failure to attend the educational institution for more than 10 days
- No consumption of zinc supplementation for more than 10 days, because of insistence to the school
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- CES Universitylead
- Nutreva S.A.S.collaborator
- Foundation Child Care - FANcollaborator
Study Sites (1)
CES University
Medellín, Antioquia, Colombia
Related Publications (1)
Sanchez J, Villada OA, Rojas ML, Montoya L, Diaz A, Vargas C, Chica J, Herrera AA. [Effect of zinc amino acid chelate and zinc sulfate in the incidence of respiratory infection and diarrhea among preschool children in child daycare centers]. Biomedica. 2014 Jan-Mar;34(1):79-91. doi: 10.1590/S0120-41572014000100011. Spanish.
PMID: 24967861DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Liliana LM Montoya, Master
CES University
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 13, 2013
First Posted
February 15, 2013
Study Start
March 1, 2012
Primary Completion
July 1, 2012
Study Completion
November 1, 2012
Last Updated
February 15, 2013
Record last verified: 2013-02